Skip to content
MARKETS / NASDAQ / HWH
NASDAQ · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

HWH International Inc. HWH

4 fiscal years on record · USD · FY2025 reported · SEC filings only
$866,926
▼ 30.8% YoY
$-2.6M
$-1.8M
In brief

What this company does

Hapi Marketplace features a selection of over forty-seven product categories including wellness, elderly care, auto accessories and more. We are expanding the product range into robotics for consumer and commercial markets. Hapi Cafés, which are, and will be, in-person, location-based social experiences, offer customers the opportunity to build a sense of community with like-minded customers who share a potential interest in our products. Our strategy is to continuously grow our F&B business.

Written from the business description in HWH International Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 26 March 2026. Every sentence was checked against that document before publication.

Growth
USD 866,926.00
Revenue, FY2025 · full 4-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.9 · Net income -2.6
0.5M1.0M-1.0M-2.0M2022202320242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−307 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -301.1% · Net -306.6%
-100%-200%-300%2022202320242025
ROE

Not applicable: equity was negative in this period, so return on equity has no meaning.

Each USD of equity lost 98 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -1.8
-1M-2M2022202320242025
Net buybacks $M Dividends $M
FY2024 · Dividends — · Net buybacks 17.5
25.0M50.0M20232024

Total assetsUSD 4.6M
EquityUSD 2.6M
CashUSD 2.1M
Current ratio2.32×

Equity funds 57% of total assets.

The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022
Revenue $B0.00.00.0·
Operating income $B−0.0−0.0−0.00.0
EBITDA $B−0.0−0.0−0.0·
Income tax $B0.0·0.00.0
Net income $B−0.0−0.0−0.00.0
Free cash flow $B−0.0−0.0−0.0·
EPS, diluted $−0.40−0.76··
Dividend / sh $····
Payout %····
ROE %−97.7···
Shares out B0.010.010.00·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 20 reconciliationsAUDITED

Reconciled in 5 of 19 fiscal years. 75 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityWholesale-Drugs, Proprietaries & Druggists' Sundries
Listed onNASDAQ
Incorporated inNevada
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image